XPO1 and B-cell chronic lymphocytic leukemia: As CLL is most often defined as a clonal expansion of malignant B lymphocytes, identifying a median E571 VAF in XPO1-mutated CLL patients to be 0.47 suggests the E571 XPO1 mutation is in the dominant clone of the total disease burden.